Skip Navigation

Cardiovascular Research 1997 33(3):641-649; doi:10.1016/S0008-6363(96)00267-2
© 1997 by European Society of Cardiology
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Izrailtyan, I.
Right arrow Articles by Kresh, J.Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Izrailtyan, I.
Right arrow Articles by Kresh, J.Y.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1997, European Society of Cardiology

Bradykinin modulation of isolated rabbit heart function is mediated by intrinsic cardiac neurons

Igor Izrailtyan and J.Yasha Kresh*

MCP- Hahnemann School of Medicine, Allegheny University of the Health Sciences, Broad & Vines Sts. MS #110, Philadelphia, PA 19102, USA

Objective: Bradykinin (BK) is an endogenous peptide exerting a potent influence on the behavior of the heart. The local regulatory mechanisms responsible for BK modulation of cardiac automaticity and contractility remain poorly understood. The role of the intrinsic cardiac nervous system (ICNS) in mediating the BK-induced regulatory effects was investigated. Methods: Heart rate (HR) and intramyocardial pressure (IMP) changes in response to BK (1.2–80 nmol) were studied in isolated rabbit hearts (n = 37). The intrinsic neural mechanisms underlying the cardiac effects of BK were characterized by use of atropine (ATR, 10–6 M), timolol (TIM, 10–5 M), hexamethonium (HEX, 10–4 M), and tetrodotoxin (TTX, 10–7 M). Modulation of β-adrenergic tone by dobutamine (DOB, 1.6 x 10–6 M) was used to expose the physiological importance of intrinsic cholinergic systems in mediating the cardiac action of BK. Results: A single dose of BK induced an increase in IMP and a biphasic HR response. The negative chronotropic response to BK was correlated with negative HR change induced by nicotine activation of ICNS. BK-elicited ‘bradycardiars was abolished by ATR and TTX, and attenuated ({approx} 50%) by HEX. ATR and TTX potentiated the positive HR-response which was not affected by TIM. BK selectively antagonized [by 48.1(5.1)%] the DOB-induced tachycardia but did not modify the accompanied inotropic potentiation. Conclusions: These findings are the first demonstration that in the autonomically decentralized heart, the negative chronotropic action of BK is mediated by intrinsic cardiac cholinergic neurons. It would appear that the intrinsic neural network response, and not merely the BK-induced potentiation of cardiac postganglionic neural activity is involved in the local neuromodulatory action of BK. This intrinsic cardiac regulatory mechanism seems to play a major role in mitigating the adrenergically induced tachycardia, thus endowing this peptide with the capacity for cardioprotection.

KEYWORDS Autonomic neural control; Cardiac ganglia; Nicotinic receptors; Cholinergic neurons; Automaticity; Contractility; Catecholamines; Rabbit

* Corresponding author. Tel. +1 215 762-1703; Fax +1215 762-7222. kresh{at}cvi.allegheny.edu

{star} A preliminary report of this study appeared in abstract form: FASEB J 1995;9(3):A340 and Circulation 1996;94(8 suppl):I489-I490.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
J. LeFebvre, A. Shintani, T. Gebretsadik, J. R. Petro, L. J. Murphey, and N. J. Brown
Bradykinin B2 Receptor Does Not Contribute to Blood Pressure Lowering during AT1 Receptor Blockade
J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1261 - 1267.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
I. Izrailtyan, J. Y. Kresh, R. J. Morris, S. C. Brozena, S. P. Kutalek, and A. S. Wechsler
Early detection of acute allograft rejection by linear and nonlinear analysis of heart rate variability
J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 737 - 745.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
C. Emanueli, R. Maestri, D. Corradi, R. Marchione, A. Minasi, M. G. Tozzi, M. B. Salis, S. Straino, M. C. Capogrossi, G. Olivetti, et al.
Dilated and Failing Cardiomyopathy in Bradykinin B2 Receptor Knockout Mice
Circulation, December 7, 1999; 100(23): 2359 - 2365.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
P. Musialek, D. J Paterson, and B. Casadei
Changes in extracellular pH mediate the chronotropic responses to L-arginine
Cardiovasc Res, August 15, 1999; 43(3): 712 - 720.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. Y. Kresh and I. Izrailtyan
Evolution in functional complexity of heart rate dynamics: a measure of cardiac allograft adaptability
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 1998; 275(3): R720 - R727.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.